TNX-102 SL Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
In United States
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.
In United StatesThis study is recruiting in the United States. It focuses on Bipolarity.
In United StatesThis study is recruiting in the United States. It focuses on depression.
In United StatesThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In United StatesThis study is recruiting in the United States and in Japan. It is testing SEP-363856 for schizophrenia.
In United StatesThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Remote / onlineThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In United StatesThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In United StatesThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In United StatesThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In United StatesThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In United StatesThis study is recruiting. It focuses on ADHD and currently lists participation information in the United States.
In United States